ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint746,904 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch instituteSchlierenLimmaTech Biologics AG
LimmaTech Biologics AG Logo
Verified· 4 sourcesTrust Score
Summary

About the company

LimmaTech Biologics AG develops vaccines against infections caused by pathogens resistant to antimicrobial treatments. Its work uses a proprietary multivalent vaccine platform and other approaches, with vaccine candidates advancing through clinical development.

AI-generated
Offering

Products & services

Industry:Research institutePharmaceutical company
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.3/5

LimmaTech Biologics AG

✓ Offered5
Vaccine development
Development of vaccine candidates against antimicrobial-resistant pathogens and bacterial infections, based on multivalent vaccine technology and pathogen-specific approaches.
Proprietary vaccine platform
Proprietary multivalent vaccine technology for developing candidates with multiple immunogenic antigens in a scalable single step, including E. coli-based and self-adjuvanting approaches.
Bioconjugation technology
In vivo enzyme-based bioconjugation for the precise conjugation of pathogen glycans with immunogenic proteins, to shorten development time and improve safety and cost structure.
Toxoid vaccine technology
Toxoid-based approach for developing vaccine candidates against bacterial toxins, with a clinical program against Staphylococcus aureus.
Clinical vaccine programs
Clinical development of vaccine candidates, including Shigella4V (S4V) and LBT-SA7, in Phase I/II and, respectively, Phase I studies.
Trust & reputation

ranQ Trust Score of LimmaTech Biologics AG: 4.3 out of 5.0

Trust Score4.3/ 5.0

Very high

x

Data basis 100% · As of November 2026

LimmaTech Biologics AG scores 69.0 out of 100 points in the Reputation area of the ranQ Trust Score. This area carries 42% of the weighting.
x
CriterionValueWeight
  • Review quality: The average rating across all connected sources, smoothed against the industry mean. So 5.0 stars from three reviews do not outrank 4.7 from three hundred.72.124%
  • Review volume: The number of reviews across all sources. The scale is logarithmic: the first reviews count the most, and the maximum is reached at 50 reviews.40.910%
  • Review recency: The age of the most recent review. Two-year-old reviews deliberately sit in the middle, because that is normal for Swiss SMEs. Only after three years without a new voice does the value drop markedly.95.08%
LimmaTech Biologics AG scores 89.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.89.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.90.07%
LimmaTech Biologics AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
LimmaTech Biologics AG scores 71.7 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.43.34%
Qualifications+0.00

LimmaTech Biologics AG reaches a ranQ Trust Score of 4.3 out of 5.0 — rated «Very high». The rating draws, among other things, on 4.8 out of 5 stars from 4 customer reviews. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Reviews

Aggregated rating

Aggregated rating
4.8
of 5

Aggregated from 4 reviews across all connected sources

Sources
GGoogle4.84
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

May 28, 2026Media
LimmaTech Biologics wird von Lilly für bis zu 780 Millionen US-Dollar übernommen
moneycab.com
May 27, 2026Media
Lilly to acquire LimmaTech Biologics for up to USD 780 million
startupticker.ch
May 27, 2026Media
Eli Lilly kauft LimmaTech Biologics für bis zu 780 Millionen Dollar
punkt4.info
February 2, 2024Media
New investment brings LimmaTech’s series A to CHF 40 million
startupticker.ch

Knowledge

No knowledge articles yet

Once LimmaTech Biologics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

LimmaTech Biologics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank LimmaTech Biologics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of LimmaTech Biologics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Grabenstrasse 3
8952 Schlieren
Opening hours
Mon
08:30 - 17:00
Tue
08:30 - 17:00
Wed
08:30 - 17:00
Thu
08:30 - 17:00
Fri
08:30 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-354.125.957
Founded
2015 · 11 years
Last commercial register change
August 10, 2026
Employees
51 to 100
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    RA
    Redbiotec AG
    Schlieren
    NA
    Neurimmune AG
    Schlieren
    CB
    C Bertozzi Services
    Schlieren
    FS
    Fortrea Switzerland AG
    Zurich
    SH
    Syneos Health Switzerland GmbH
    Zurich
    CS
    Celerion Switzerland AG
    Fehraltorf
    CA
    Clinipace AG
    Volketswil
    BG
    BEROtech GmbH
    Oetwil Am See